BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34493029)

  • 1. Distal spread and tumor regression patterns following preoperative chemoradiotherapy in rectal cancer patients.
    Özer İ; Zengin Nİ; Çaycı HM; Yüksel A; Dalgıç T; Ulaş M; Bostancı EB; Akoğlu M
    Turk J Med Sci; 2021 Dec; 51(6):2978-2985. PubMed ID: 34493029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin?
    Mezhir JJ; Smith KD; Fichera A; Hart J; Posner MC; Hurst RD
    Surgery; 2005 Oct; 138(4):658-63; discussion 663-4. PubMed ID: 16269294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.
    Guedj N; Maggiori L; Poté N; Norkowski E; Cros J; Bedossa P; Panis Y
    Hum Pathol; 2016 Jun; 52():164-72. PubMed ID: 27210028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer.
    Song SH; Park JS; Choi GS; Seo AN; Park SY; Kim HJ; Lee SM; Yoon G
    Sci Rep; 2021 Nov; 11(1):22943. PubMed ID: 34824330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT.
    Perez RO; Habr-Gama A; Smith FM; Kosinski L; São Julião GP; Grzona E; Rawet V; Vianna MR; Proscurshim I; Lynn PB; Gama-Rodrigues J
    J Surg Oncol; 2014 Jun; 109(8):853-8. PubMed ID: 24862927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
    Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
    Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of P53-immunohistochemistry in large slice in evaluating distal intramural spread extent in rectal cancer].
    Pan ZZ; Wan DS; Zhang CQ; Shao JY; Li LR; Chen G; Zhou ZW; Lu ZH; Wang FL
    Ai Zheng; 2004 Oct; 23(10):1199-202. PubMed ID: 15473935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.
    Sung S; Kim SH; Lee JH; Nam TK; Jeong S; Jang HS; Song JH; Lee JW; Bae JM; Lee JH
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):647-653. PubMed ID: 28581407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.
    Frambach P; Pucciarelli S; Perin A; Zuin M; Toppan P; Maretto I; Urso EDL; Spolverato G
    Colorectal Dis; 2018 Dec; 20(12):O326-O334. PubMed ID: 30230157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.
    Lin SC; Chen PC; Lee CT; Tsai HM; Lin PC; Chen HH; Wu YH; Lin BW; Su WP; Lee JC
    World J Gastroenterol; 2013 Mar; 19(11):1797-804. PubMed ID: 23555168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy.
    Sakuyama N; Kojima M; Kawano S; Matsuda Y; Mino-Kenudson M; Ochiai A; Ito M
    Cancer Sci; 2018 Mar; 109(3):871-878. PubMed ID: 29388280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
    Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
    Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome.
    Mezhir JJ; Shia J; Riedel E; Temple LK; Nash GM; Weiser MR; Paty PB; Wong WD; Guillem JG
    Ann Surg; 2012 Aug; 256(2):274-9. PubMed ID: 22791103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.